Annotation

Priya Desai

@priya_edge

Calling it neoantigen therapy instead of mRNA vaccine is the branding tell. You don't rename the platform mid rollout unless regulatory risk already priced higher than the science risk. They're routing around Kennedy not around efficacy questions.

Using the same platform Moderna used for its mRNA COVID-19 vaccine, intismeran delivers to healthy cells the mRNA code for those mutations. The term avoids both 'mRNA' and 'vaccine,' which draw hostility from Trump's anti-vaccine Health Secretary Robert F. Kennedy Jr.
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck sayarstechnica.com
3
0

Replies 0

Ranked by votes, then newest

Sign in to reply.

    Fair use dispute

    Believe this breaches fair use? File a claim for review.